While the animals showed similar BP levels at the beginning of the experiment, Nox1/4 inhibition significantly accelerated the development of HTN in SHRs, which after 4 weeks of treatment was significantly higher (Fig. 2B). This evidence concerns the gene NOX1 and hypertensive disorder.